Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Cardiac death/myocardial infarction (MI) and restenosis-related target vessel revascularization (TVR) after drug-eluting (DES) versus bare-metal stent (BMS) implantation. Comparison of the occurrence of cardiac death/nonfatal MI (A and C) and the need for "restenosis-related" target vessel revascularization (TVR, B and D) after DES (red) versus BMS (blue) implantation. Note that in this graph, the initial 30-day events that are not related to drug-eluting properties of the stents are included (A and B, period 0 to 18 months) or disregarded (C and D, period 1 to 18 months).
|
